According to Immix Biopharma's latest financial reports the company's current earnings (TTM) are -โฌ17.85 M. In 2023 the company made an earning of -โฌ14.2 M a decrease over its 2022 earnings that were of -โฌ7.42 M.The earnings displayed on this page is the company's Pretax Income.